Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 7/2015

01.07.2015 | Inflammatory Disorders

Clinical features of psoriatic uveitis in Japanese patients

verfasst von: Rie Tanaka, Mitsuko Takamoto, Keiko Komae, Kazuyoshi Ohtomo, Yujiro Fujino, Toshikatsu Kaburaki

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 7/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the clinical features of psoriatic uveitis in Japanese patients.

Methods

Clinical features of 13 consecutive patients with psoriatic uveitis treated at our facility were retrospectively examined using medical records. In this study, we collected data about psoriasis type, uveitis laterality, onset type, HLA types, visual acuity, ocular inflammation localization, anterior segment findings, funduscopy findings, complications, recurrence, and medical treatments for uveitis and skin diseases.

Results

The cohort comprised ten males and three females (43.6 ± 7.1 years old), and types of psoriasis included psoriasis vulgaris (seven cases), psoriatic arthritis (four cases), pustular psoriasis (three cases) and psoriatic erythroderma (one case). Two cases represented complicated cases of pustular psoriasis and psoriatic arthritis. Seven cases were unilateral, and six cases were bilateral. All cases had acute non-granulomatous anterior uveitis, whereas panuveitis occurred in one case. Furthermore, macular edema and vascular leakage on fluorescein angiography occurred in four cases, and hyperemic disc occurred in two cases. Recurrence occurred in nine cases. In addition to topical corticosteroid treatment, eight cases underwent oral immunosuppressive treatment or biologics. All six cases undergoing HLA typing were HLA-A2 positive.

Conclusions

Cases of psoriatic uveitis in Japan appear to present with acute non-granulomatous uveitis; other symptoms may include macular edema, retinal vasculitis, or hyperemic disc.
Literatur
2.
Zurück zum Zitat Aso K, Amano M (1984) Number of psoriasis patients in Yamagata prefecture. Hifu Rinsho 26:585–589 [In Japanese] Aso K, Amano M (1984) Number of psoriasis patients in Yamagata prefecture. Hifu Rinsho 26:585–589 [In Japanese]
3.
Zurück zum Zitat Nestle FO, Kaplan DH, Barker J (1976) Psoriasis. N Engl J Med 361:496–509CrossRef Nestle FO, Kaplan DH, Barker J (1976) Psoriasis. N Engl J Med 361:496–509CrossRef
5.
Zurück zum Zitat Catsarou-Catsari A, Katsambas A, Theodoropoulos P et al (1984) Ophthalmological manifestations in patients with psoriasis. Acta Derm Venereol 64:557–559PubMed Catsarou-Catsari A, Katsambas A, Theodoropoulos P et al (1984) Ophthalmological manifestations in patients with psoriasis. Acta Derm Venereol 64:557–559PubMed
6.
Zurück zum Zitat Chandran NS, Greaves M, Gao F et al (2007) Psoriasis and the eye: prevalence of eye disease in Singaporean Asian patients with psoriasis. J Dermatol 34:805–810PubMedCrossRef Chandran NS, Greaves M, Gao F et al (2007) Psoriasis and the eye: prevalence of eye disease in Singaporean Asian patients with psoriasis. J Dermatol 34:805–810PubMedCrossRef
7.
Zurück zum Zitat Niccoli L, Nannini C, Cassarà E et al (2012) Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Int J Rheum Dis 15:414–418PubMedCrossRef Niccoli L, Nannini C, Cassarà E et al (2012) Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Int J Rheum Dis 15:414–418PubMedCrossRef
8.
9.
Zurück zum Zitat Keino H, Sakai J, Usui M (2003) Association between HLA-A2 in Japanese psoriasis arthritis and susceptibility to uveitis. Graefes Arch Clin Exp Ophthalmol 241:777–778PubMedCrossRef Keino H, Sakai J, Usui M (2003) Association between HLA-A2 in Japanese psoriasis arthritis and susceptibility to uveitis. Graefes Arch Clin Exp Ophthalmol 241:777–778PubMedCrossRef
10.
Zurück zum Zitat Okunuki Y, Kezuka T, Usui Y et al (2008) Review of uveitis associated with psoriasis. Rinsho Ganka (Jpn J Clin Ophthalmol) 62:897–901 [In Japanese] Okunuki Y, Kezuka T, Usui Y et al (2008) Review of uveitis associated with psoriasis. Rinsho Ganka (Jpn J Clin Ophthalmol) 62:897–901 [In Japanese]
11.
Zurück zum Zitat Watanabe Y, Kambara T, Sano S et al (2012) Therapeutic effects for infliximab in psoriatic uveitis; case report and review of the literature in Japan. Jpn J Dermatol 122:2321–2327 [In Japanese] Watanabe Y, Kambara T, Sano S et al (2012) Therapeutic effects for infliximab in psoriatic uveitis; case report and review of the literature in Japan. Jpn J Dermatol 122:2321–2327 [In Japanese]
12.
Zurück zum Zitat Iijima S, Iwata M, Otsuka F (1996) Psoriatic arthritis and hypopyon-iridocyclitis. Possible mechanism of the association of psoriasis and anterior uveitis. Dermatology 193:295–299PubMedCrossRef Iijima S, Iwata M, Otsuka F (1996) Psoriatic arthritis and hypopyon-iridocyclitis. Possible mechanism of the association of psoriasis and anterior uveitis. Dermatology 193:295–299PubMedCrossRef
13.
Zurück zum Zitat Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516PubMedCrossRef Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516PubMedCrossRef
14.
Zurück zum Zitat Catanoso M, Pipitone N, Salvarani C (2012) Epidemiology of psoriatic arthritis. Reumatismo 64:66–70PubMedCrossRef Catanoso M, Pipitone N, Salvarani C (2012) Epidemiology of psoriatic arthritis. Reumatismo 64:66–70PubMedCrossRef
15.
Zurück zum Zitat Takahashi H, Nakamura K, Kaneko F, Nakagawa H, Iizuka H (2011) Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002–2008. J Dermatol 38:1125–1129PubMedCrossRef Takahashi H, Nakamura K, Kaneko F, Nakagawa H, Iizuka H (2011) Analysis of psoriasis patients registered with the Japanese Society for Psoriasis Research from 2002–2008. J Dermatol 38:1125–1129PubMedCrossRef
16.
Zurück zum Zitat Durrani K, Foster CS (2005) Psoriatic uveitis: a distinct clinical entity? Am J Ophthalmol 139:106–111PubMedCrossRef Durrani K, Foster CS (2005) Psoriatic uveitis: a distinct clinical entity? Am J Ophthalmol 139:106–111PubMedCrossRef
17.
Zurück zum Zitat Dhir L, Prasad SD (2006) Psoriatic uveitis-associated cystoid macular oedema treated with intravitreal triamcinolone acetonide. Acta Ophthalmol Scand 84:436–437PubMedCrossRef Dhir L, Prasad SD (2006) Psoriatic uveitis-associated cystoid macular oedema treated with intravitreal triamcinolone acetonide. Acta Ophthalmol Scand 84:436–437PubMedCrossRef
18.
19.
Zurück zum Zitat Huynh N, Cervantes-Castaneda RA, Bhat P et al (2008) Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm 16:89–93PubMedCrossRef Huynh N, Cervantes-Castaneda RA, Bhat P et al (2008) Biologic response modifier therapy for psoriatic ocular inflammatory disease. Ocul Immunol Inflamm 16:89–93PubMedCrossRef
20.
Zurück zum Zitat Simonini G, Druce K, Cimaz R, Macfarlane GJ, Jones GT (2014) Current evidence of anti-tumor necrosis factor alpha treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs. Arthritis Care Res 66:1073–1084CrossRef Simonini G, Druce K, Cimaz R, Macfarlane GJ, Jones GT (2014) Current evidence of anti-tumor necrosis factor alpha treatment efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach of individual drugs. Arthritis Care Res 66:1073–1084CrossRef
21.
Zurück zum Zitat Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Januschowski K, Voykov B, Deuter C (2014) Immunomodulatory therapy with tumour necrosis factor alpha inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results. Br J Ophthalmol 98:523–528PubMedCrossRef Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Januschowski K, Voykov B, Deuter C (2014) Immunomodulatory therapy with tumour necrosis factor alpha inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results. Br J Ophthalmol 98:523–528PubMedCrossRef
22.
Zurück zum Zitat Smith JR, Levinson RD, Holland GN, Jabs DA, Robinson MR, Whitcup SM, Rosenbaum JT (2001) Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 4:252–257CrossRef Smith JR, Levinson RD, Holland GN, Jabs DA, Robinson MR, Whitcup SM, Rosenbaum JT (2001) Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum 4:252–257CrossRef
23.
Zurück zum Zitat Kakkassery V, Mergler S, Pleyer U (2010) Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment. Curr Eye Res 35:751–756PubMedCrossRef Kakkassery V, Mergler S, Pleyer U (2010) Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment. Curr Eye Res 35:751–756PubMedCrossRef
24.
Zurück zum Zitat Tsuchiya K, Kimura A, Kondo M, Nishimura Y, Sasazuki T (2001) Combination of HLA-A and HLA class II alleles controls the susceptibility to rheumatoid arthritis. Tissue Antigens 58:395–401PubMedCrossRef Tsuchiya K, Kimura A, Kondo M, Nishimura Y, Sasazuki T (2001) Combination of HLA-A and HLA class II alleles controls the susceptibility to rheumatoid arthritis. Tissue Antigens 58:395–401PubMedCrossRef
25.
26.
Zurück zum Zitat Akesaka T, Kashiwase K, Shimamura M et al (2000) Identification of a novel HLA-B46 allele, B*4602, in Japanese. Tissue Antigens 55:460–462PubMedCrossRef Akesaka T, Kashiwase K, Shimamura M et al (2000) Identification of a novel HLA-B46 allele, B*4602, in Japanese. Tissue Antigens 55:460–462PubMedCrossRef
27.
Zurück zum Zitat Muto M, Nagai K, Mogami S et al (1995) HLA antigens in Japanese patients with psoriatic arthritis. Tissue Antigens 45:362–364PubMedCrossRef Muto M, Nagai K, Mogami S et al (1995) HLA antigens in Japanese patients with psoriatic arthritis. Tissue Antigens 45:362–364PubMedCrossRef
Metadaten
Titel
Clinical features of psoriatic uveitis in Japanese patients
verfasst von
Rie Tanaka
Mitsuko Takamoto
Keiko Komae
Kazuyoshi Ohtomo
Yujiro Fujino
Toshikatsu Kaburaki
Publikationsdatum
01.07.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 7/2015
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-015-2968-4

Weitere Artikel der Ausgabe 7/2015

Graefe's Archive for Clinical and Experimental Ophthalmology 7/2015 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.